Clinical trial
National Cooperative Growth Study (NCGS): A Post-marketing Surveillance Program…
NCT00097539 · Genentech, Inc., Industry · Completed
Key facts
| NCT number | NCT00097539 |
|---|---|
| Title | National Cooperative Growth Study (NCGS): A Post-marketing Surveillance Program for Nutropin, Nutropin AQ, Nutropin Depot, and Protropin |
| Official title | Genentech National Cooperative Growth Study (NCGS) Post-Marketing Surveillance Program For Nutropin AQ® (Somatropin [rDNA Origin] Injection), Nutropin® (Somatropin [rDNA Origin] for Injection), and Protropin® (Somatrem for Injection) |
| Lead sponsor | Genentech, Inc., Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Growth Disorders |
| Intervention type | Biological |
| Interventions | Somatrem, Somatropin |
| Enrollment | 65,205 |
| Start date | Oct 1, 1985 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Nov 25, 2004 |
| Last update posted | Feb 15, 2017 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: